Journal of general and family medicine · 2026
Nocturnal BiPAP Therapy Improved Chronic Respiratory Failure in Chilaiditi Syndrome.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kouga Takeshi, Tsukamoto Reizo
Аннотация
BACKGROUND: Chilaiditi syndrome includes the Chilaiditi sign, a radiological finding where a segment of bowel loop or small intestine has wandered between the liver and diaphragm and also any symptoms related to intestinal interference.
CASE PRESENTATION: We report the case of a 79-year-old man with Chilaiditi syndrome whose dyspnea and sleep disturbance improved after nocturnal biphasic positive airway pressure (BiPAP) therapy implementation.
DISCUSSION: BiPAP therapy may contribute to thoracic pressure elevation and reduce diaphragmatic compression due to intestinal enlargement, thus leading to improvements in respiratory symptoms.
CONCLUSION: BiPAP therapy should therefore be considered as a treatment option for Chilaiditi syndrome patients.
CASE PRESENTATION: We report the case of a 79-year-old man with Chilaiditi syndrome whose dyspnea and sleep disturbance improved after nocturnal biphasic positive airway pressure (BiPAP) therapy implementation.
DISCUSSION: BiPAP therapy may contribute to thoracic pressure elevation and reduce diaphragmatic compression due to intestinal enlargement, thus leading to improvements in respiratory symptoms.
CONCLUSION: BiPAP therapy should therefore be considered as a treatment option for Chilaiditi syndrome patients.